Quest Diagnostics (DGX)

Quest Diagnostics (DGX) Financial Statements


Quest Diagnostics Financial Overview

Quest Diagnostics's market cap is currently ―. The company's EPS TTM is $7.431; its P/E ratio is 18.70; and it has a dividend yield of 2.07%. Quest Diagnostics is scheduled to report earnings on July 23, 2024, and the estimated EPS forecast is $2.33. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 2.29B$ 2.29B$ 2.34B$ 2.33B$ 2.33B
Gross Profit$ 736.00M$ 754.00M$ 2.34B$ 771.00M$ 758.00M
EBIT-$ 322.00M$ 306.00M$ 208.00M$ 89.00M
EBITDA-$ 433.00M$ 418.00M$ 315.00M-
Net Income Common Stockholders$ 192.00M$ 225.00M$ 235.00M$ 202.00M$ 101.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 686.00M$ 143.00M$ 126.00M$ 175.00M$ 315.00M
Total Assets$ 14.02B$ 13.48B$ 13.43B$ 12.79B$ 12.84B
Total Debt$ 5.37B$ 4.91B$ 4.96B$ 4.62B$ 4.62B
Net Debt$ 4.68B$ 4.77B$ 4.83B$ 4.45B$ 4.31B
Total Liabilities$ 7.60B$ 6.94B$ 7.06B$ 6.63B$ 12.84B
Stockholders Equity$ 6.31B$ 6.42B$ 6.25B$ 6.05B$ 5.89B
Cash Flow-
Free Cash Flow-$ 102.00M$ 340.00M$ -33.00M$ 187.00M
Operating Cash Flow$ 527.00M$ 207.00M$ 444.00M$ 94.00M$ 334.00M
Investing Cash Flow$ -114.00M$ -107.00M$ -682.00M$ -158.00M$ -174.00M
Financing Cash Flow$ 130.00M$ -83.00M$ 189.00M$ -76.00M$ -545.00M
Currency in USD

Quest Diagnostics Earnings and Revenue History

Quest Diagnostics Debt to Assets

Quest Diagnostics Cash Flow

Quest Diagnostics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis